Despite the rare detection of EV RNA in the CNS of patients with AFM, a pan-viral serologic 87 assay identified high levels of CSF EV antibodies in AFM CSF compared to CSF from OND 88 controls. These results provide further evidence for a causal role of non-polio enteroviruses in 89 AFM. 90
Introduction 91
First detected in California in 2012, the United States has experienced seasonal, biennial 92 increases in the incidence of acute flaccid myelitis (AFM) cases. 1 Since 2014, the Centers for 93 Disease Control and Prevention (CDC) has reported over 500 confirmed cases. [2] [3] [4] [5] [6] The nationwide 94 surges in AFM in 2014, 2016, and 2018 have coincided temporally and geographically with 95 outbreaks of enterovirus (EV) D68 and EV-A71 infections. 3,7-10 EVs, including poliovirus, are 96 well recognized for their neuroinvasive capacity and resultant central nervous system (CNS) 97 pathology, ranging from self-resolving aseptic meningitis to fulminant, sometimes fatal, 98 brainstem encephalitis, and to myelitis leading to permanent debilitating paralysis. 11 99 100 Despite the temporal association between EV-D68 and EV-A71 outbreaks and AFM and a 101 mouse model that recapitulates the AFM phenotype with a contemporary EV-D68 strain, 12 the 102 etiology of AFM has been difficult to confirm. 13, 14 Thus, concerns persist that AFM could result 103 from yet-to-be-identified pathogens or a para-infectious immune response. This is due, in part, to 104 the fact that less than half of children with AFM have had EV detected in a non-sterile biologic 105 specimen (nasopharyngeal or oropharyngeal swabs most commonly, rectal and stool samples less 106 commonly), and no other alternative candidate etiologic agents have been identified in the 107 remaining children. 4 In addition, only 2% of children with AFM have EV nucleic acid detected 108 in cerebrospinal fluid (CSF) . 15, 16 109 110 The immune privileged status of the CNS makes direct detection of viral nucleic acid or indirect 111 discovery of intrathecal anti-viral antibodies an important step in linking a pathogen to a 112 neuroinfectious disease. We interrogated CSF from AFM patients (n=42) from recent outbreaks with unbiased ultra-deep metagenomic next-generation sequencing (mNGS), including with a 114 novel CRISPR-Cas9 based enrichment technique. Furthermore, to search for virome-wide 115 antibody signals that might be associated with AFM, we employed the VirScan approach that 116 was previously developed to detect antibodies to all known human viruses. 17 To improve upon 117 this detection method we generated a large and more finely tiled peptide library in the T7 phage 118 (reads per hundred thousand (rpK)). [25] [26] [27] Phage results were filtered using a cutoff fold-change of 160 greater than 10 above the mean background rpK generated from null IPs. 161
162

Independent Validation with ELISA 163
To independently validate our VirScan results, we generated recombinant viral protein 1 (VP1) 164 from recent AFM-associated EV-A71 and EV-D68 strains and performed ELISA to detect EV 165 antibodies with AFM CSF samples for which sufficient CSF remained (n=26) and OND controls 166 (n=50). Signal was measured as the optical density (OD) at 450 nm. For each sample, we 167 considered the higher of the two (EV-A71 or EV-D68) OD values when analyzing cases and 168 controls. 169
170
Results 171
Cases and Controls 172
42 AFM cases and 58 OND controls were included in the study (Supplemental Figure 1 ). Patient 173 demographics are described in Table 1 . The AFM cases were younger (median age 37.8 months, 174 interquartile range [IQR], 11 to 64 months) than the OND controls (median age 120 months, 175 IQR, 66 to 174 months), with a p-value of 0.0497 (as determined by an unpaired parametric t-176 test). There was a higher proportion of males in the AFM cases. AFM cases and OND controls 177 from the Western and Northeastern USA (Supplemental Figure 2 ) make up the majority of both 178 categories. Cases from 2018 make up the majority of the AFM cases. 179 180 We obtained an average of 433 million 150 nt paired-end reads per sample (range, 304 -569 183 million reads per sample). Based on the ERCC RNA spike-ins, we estimated that our mean limit 184 of detection was 5.48 attograms (range, 3.92 to 17.47 attograms). 21 EV-A71 was detected in one 185 AFM sample at 71.31 rpM (1497.3 rpM in FLASH-NGS, Supplemental Table 3 ). This sample 186 was previously known to be EV-A71 positive by Sanger sequencing. No other pathogenic 187 organisms were detected in this or any of the other AFM samples. 188
Ultra-Deep Metagenomic Next-Generation Sequencing Rarely Detects Enterovirus in 181
189
CSF VirScan Testing Detects Enterovirus in AFM 190
The most significantly enriched viral family by VirScan of CSF in AFM cases (n = 42) versus 191 OND controls (n = 58) was Picornaviridae (mean rpK 11,266, IQR 16,324 versus mean rpK 950 192 IQR 948, p-adjusted = 1 x 10 -7 Wilcoxon signed-rank test with Bonferroni adjustment, 193 Supplemental Table 4 ). Enriched Picornaviridae peptides belonged almost entirely to the genus 194 Enterovirus ( Figure 1A -C, Supplemental Table 5 ). Peptides mapping to Caliciviridae, 195 Ascoviridae, Baculoviridae and unclassified viruses were also significantly enriched in AFM 196 relative to OND controls (p-adjusted = 0.004, 0.025, 0.021, and 0.039, respectively by Wilcoxon 197 signed-rank test with Bonferroni adjustment) but with a mean rpK 6.4 to 74.7 times lower than 198 for Picornaviridae ( Figure 1A and Supplemental Table 4 ). We detected 3.4-fold more 199
Caliciviridae in AFM versus OND (mean rpK 151 IQR 132 versus mean rpK 44 IQR 0, p-200 adjusted < 0.01). We did not further consider viruses with non-human hosts. 201 202 Enriched EV peptides were derived from proteins across the EV genome (Figure 2A , 203 Supplemental Table 6 ). Among capsid protein sequences, KVPALQAAEIGA in VP1 has been 204 previously reported to be an immunodominant linear EV epitope. 28 Peptides containing this and S c h u b e r t e t a l . 1 1 related overlapping epitopes were enriched in our data across AFM patients, with multiple 206 sequence alignment revealing a consensus motif of PxLxAxExG ( Figure 2B ). Another 207 immunodominant epitope was to a conserved, linear portion of 3D pol ( Figure 2C ). 208 209
Enterovirus VP1 ELISA confirms VirScan Findings 210
Consistent with the VirScan data, the mean EV VP1 ELISA signal in AFM (n = 26, mean OD 211 0.51 IQR 0.56) was significantly higher than OND controls (n = 50, mean OD 0.08 IQR 0.06, p-212 value < 0.001 by Mann-Whitney test, Figure 3 and Supplemental Table 7 ). Mean EV signal 213 detected by phage and ELISA demonstrated a linear correlation (R 2 = 0.48, p-value < 0.001, 214
Supplemental Figure 2 ). Among AFM patients, mean CSF EV antibody detected by either 215 ELISA or VirScan did not differ based on whether EV RNA had been previously detected (n 216 =15) or not (n = 11, mean OD 0.41 versus 0.65 by ELISA; mean rpK 6,444 vs 13,975 by 217 VirScan, p-value = not significant for both comparisons). We attempted to identify whether a 218 patient was infected with either EV-A71 or EV-D68 using both VirScan and ELISA but both 219 assays yielded cross-reactivity, an expected issue with EV ELISA (Supplemental Figure 3 ). We 220 did not observe an obvious independent effect of geography, year, or season on either the 221 VirScan total EV or the ELISA VP1 EV data . 222 223
Discussion 224
We combined unbiased ultra-deep mNGS with an adaption of the VirScan method 17 for 225 comprehensively detecting anti-viral antibodies to query CSF from a relatively large (n=42) and 226 geographically diverse subset of children presenting with AFM since 2014. 17 Ultra-deep mNGS 227 combined with FLASH enrichment for EV-A71 and EV-D68 confirmed the presence of EV RNA in a single sample that was previously known to be positive for EV-A71 by PCR and failed 229 to discover any other pathogen. There are a number of possible reasons for the lack of detectable 230 EV nucleic acid in the CSF of AFM patients by mNGS or other methods. Clinically, 231 radiologically and similarly to poliomyelitis, the CNS tissue involved in AFM is often restricted 232 to the anterior horn cells in the cervical spinal cord, making it possible that little to no virus is 233 shed into the CSF. In addition, children with AFM typically present with neurologic symptoms a 234 median of 5-7 days after prodromal illness onset, decreasing the probability of RNA detection. 29 235
Lack of consistent identification of viral nucleic acid in CSF is not limited to AFM, rather 236 it is common to a wide range of neuroinvasive viruses, including poliovirus, rabies, West Nile 237 virus, and other arboviruses. 30 As a result, detection of intrathecal antibody production through 238 CSF serologic testing is the gold standard for diagnosis of many neuroinvasive viruses, notably 239
West Nile virus and varicella zoster virus. 31,32 Thus, we supplemented CSF mNGS with VirScan 240 to comprehensively profile CSF anti-viral antibodies in AFM cases and OND controls. VirScan 241 revealed high levels of CSF immunoreactivity to immunodominant EV epitopes in AFM, 242 independent of whether EV RNA had previously been detected in clinical testing of CSF or 243 nonsterile sites. Independent testing with EV-A71 and EV-D68 VP1 ELISAs confirmed these 244 findings. VirScan and whole VP1 ELISA were not able to consistently identify specific binding 245 to individual EV types, likely owing to cross-reactive immune responses to conserved, linear EV 246 antigens. 33 There was a non-significant trend towards greater enrichment of EV antibodies in 247 patients without directly detectable virus in a peripheral site, possibly owing to the rise in titer 248 that occurs in the weeks following an infection. 249
This study has important limitations. First, detection of a serologic response to a virus at a single 251 time point by itself does not fulfill Koch's postulates for establishing causality between a virus 252 and a particular disease. However, these serologic data support the specificity of the CSF 253 antibody response to EVs in AFM, helping fulfill the Bradford Hill criteria for making a causal 254 association. 13, 14 Second, further work will be necessary to establish, in a prospective manner, the 255 diagnostic sensitivity and specificity for CSF EV serology, and thus we have only reported 256 population level means and medians for our results. Third, our cases and controls were not 257 optimally matched. Controls had OND, but case and control populations were not similar by age, 258
year, or season, which are important risk factors for enterovirus infection in the United States. 259
However, we did not see a significant effect of year or season on EV signal by VirScan or 260 ELISA in the OND controls. Fourth, we did detect a statistically increased amount of signal to 261
Caliciviridae in the AFM cases. However, the magnitude of signal was much less than for 262
Picornaviridae and Enterovirus, and its clinical relevance is unclear as this family of viruses is 263 not typically associated with neuroinvasive disease. We chose to report these preliminary 264 findings, despite the limitations of the study design, because of the public health urgency of 265 understanding the etiology of AFM. A prospective study with matched cases and controls is 266 necessary to confirm our findings. 267 268 AFM is a potentially devastating neurologic syndrome whose incidence of reported cases has 269 risen in the US since 2014 with biennial peaks. In addition, cases have now been detected in 14 270 other countries across 6 continents. 29 There are no proven treatments for AFM, and like 271 poliomyelitis, a vaccine may ultimately be the most effective prevention strategy. However, it is 272 important to first achieve consensus around the likely etiologic agents. While continued intensities reflect +11,000 and -11,000 rpK, respectively. The strongest intensity is observed in VirScan with no differences seen when comparing EV signal in those with previously detected 327 (n=23) and previously undetected (n=19) EV infection (p = ns). When each group was compared 328 to the OND controls (n=58), both demonstrated significant enrichment of EV signal (p < 0.001; 329
Mann-Whitney signed-rank test with Bonferroni adjustment for multiple comparisons). 
